The first Coronavirus vaccine trial is officially underway

The search for protection against the Coronavirus is underway, according to health officials.

US researchers administered the first shot of a potential COVID-19 vaccine to a healthy volunteer Monday at the Kaiser Permanente Washington Research Institute in Seattle, as scientists around the world search for protection with the widespread pandemic.

The Associated Press observed the study where participants received the injection. In total, four participants were part of the study on Monday where they’d be given two doses of the vaccine via upper arm injections a month apart.

Forty-five male and non-pregnant females would be given the vaccine, according to the study.

Dr. Anthony Fauci of the US National Institutes of Health warned while Monday was the beginning of figuring out how to combat Coronavirus, a vaccine wouldn’t be available for global use for 12 to 18 months.

“This Phase 1 study, launched in record speed, is an important first step toward achieving that goal,” Fauci said in a statement, according to CNBC.

The Coronavirus pandemic has killed at least 6,500 people and sickened nearly 170,000 people around the globe.

Dr. Lisa Jackson, the study leader, said it’s an incredible feat to have made ground on a potential vaccine, but it will take time.

“We don’t know whether this vaccine will induce an immune response, or whether it will be safe. That’s why we’re doing a trial,” Jackson said to the AP. “It’s not at the stage where it would be possible or prudent to give it to the general population.”